Bioptix Inc news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

BIOP 3.63 +0.03 (0.83%)
price chart
Bioptix Reports Board of Director Changes
6, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP), (the "Company"), announced that Gail Schoettler, Susan Evans and David Welch have resigned from the Company's Board of Directors.
BRIEF-Catherine Johanna Defrancesco reports 11.45 pct stake in Bioptix Inc
Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news ...
Bioptix Inc.
Check out the returns on our 8 Lazy Portfolios that are made up of low-cost buy-and-hold index funds. • How to create your own Lazy Portfolio.
Honig Is Buying Again: This Time, Bioptix Inc. (NASDAQ:BIOP)
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Bioptix Inc. (NASDAQ:BIOP) reported that Honig Barry C. has picked up 504,000 of common stock as of 2017-01-05.
Insider Trading Activity Venaxis, Inc. (NASDAQ:BIOP) – Major Shareholder ...  Market Exclusive
Bioptix, Inc. (NASDAQ:BIOP) Files An 8-K Departure of Directors or Certain ...
Bioptix, Inc. (NASDAQ:BIOP) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to ...
BOULDER, Colo., Dec. 8, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced that following the approval from shareholders at the 2016 Annual Meeting of Shareholders of the proposal to change the Company's name, the Company's name has ...
Venaxis (APPY) Changes Name to Bioptix; Will Trade Under Ticker 'BIOP'
Venaxis Announces Acquisition of BiOptix
13, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced today that it has acquired BiOptix Diagnostics, Inc., ("BiOptix") a Boulder, CO-based privately-held company. BiOptix has developed a proprietary Enhanced Surface Plasmon Resonance ...
Bioptix, Inc. (NASDAQ:BIOP) Files An 8-K Other Events
As previously disclosed in the Current Report on Form 8-K filed with the Commission on December 2, 2016, effective as of November 30, 2016, Bioptix, Inc., formerly known as Venaxis, Inc. (the “Company”) changed its name from “Venaxis, Inc.” to “Bioptix ...
Shareholder forces out Bioptix board members
BOULDER - A spat between management of Boulder-based Bioptix Inc. (Nasdaq: BIOP) and a Florida shareholder has forced the resignation of three members of the company's board of directors.
Colorado biotech shakes up its board
Barry C. Honig Acquires 4000 Shares of Venaxis, Inc. (BIOP) Stock  Community Financial News
Castle Rock firm Venaxis acquires Boulder-based BiOptix Diagnostics
BOULDER - Castle Rock biotechnology firm Venaxis Inc. (Nasdaq: APPY) has acquired Boulder-based BiOptix Diagnostics Inc. in an all-stock transaction worth roughly $2.6 million, with plans for the combined operation to be located in Boulder.